Overview A Study of BGM0504 in Chinese Patients With Type 2 Diabetes Status: COMPLETED Trial end date: 2024-08-13 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of BGM0504 in Chinese patients with Type 2 Diabetes.Phase: PHASE2 Details Lead Sponsor: BrightGene Bio-Medical Technology Co., Ltd.